Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medullary carcinoma of thyroid
|
71 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.070 | 0.857 | 7 | 2009 | 2017 | |||||
Neoplasms
|
1644 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.040 | 0.750 | 4 | 2005 | 2012 | |||||
Papillary thyroid carcinoma
|
204 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.030 | 1.000 | 3 | 2005 | 2015 | |||||
THYROID CARCINOMA, SPORADIC MEDULLARY
|
11 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Adrenal Gland Pheochromocytoma
|
50 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 2 | 2014 | 2017 | ||||||
Cutaneous Melanoma
|
248 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 1.000 | 2 | 2009 | 2012 | |||||
Desmoplastic melanoma
|
2 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Malignant neoplasm of pancreas
|
277 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 1.000 | 2 | 2005 | 2009 | |||||
Multiple endocrine neoplasia Type 2
|
38 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 1.000 | 2 | 2004 | 2011 | |||||
Multiple Endocrine Neoplasia Type 2a
|
44 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 0.500 | 2 | 2004 | 2006 | |||||
Pheochromocytoma
|
186 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 2 | 2014 | 2017 | ||||||
Thyroid Neoplasm
|
135 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.020 | 1.000 | 2 | 2002 | 2015 | |||||
Carcinogenesis
|
355 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Differentiated Thyroid Gland Carcinoma
|
80 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Familial medullary thyroid carcinoma
|
45 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Follicular thyroid carcinoma
|
28 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Hirschsprung Disease
|
162 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 1999 | 1999 | |||||
Malignant desmoplastic melanoma
|
1 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of thyroid
|
103 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
melanoma
|
515 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Pancreatic carcinoma
|
322 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Pancreatic Neoplasm
|
20 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Primary differentiated carcinoma of thyroid gland
|
41 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Primary vesicoureteric reflux
|
1 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1 | 2009 | 2009 | ||||||
Thyroid carcinoma
|
145 | 0.658 | 0.280 | 10 | 43114671 | missense variant | G/A;C;T | snv | 0.21 | 0.010 | 1.000 | 1 | 2015 | 2015 |